Hong, Jung Yong http://orcid.org/0000-0003-1363-9332
Cho, Hee Jin
Sa, Jason K.
Liu, Xiaoqiao
Ha, Sang Yun
Lee, Taehyang
Kim, Hajung
Kang, Wonseok
Sinn, Dong Hyun
Gwak, Geum-Youn
Choi, Moon Seok
Lee, Joon Hyeok
Koh, Kwang Cheol
Paik, Seung Woon
Park, Hee Chul
Kang, Tae Wook
Rhim, Hyunchul
Lee, Su Jin
Cristescu, Razvan
Lee, Jeeyun
Paik, Yong Han
Lim, Ho Yeong
Funding for this research was provided by:
ministry of health & welfare, republic of korea (HR20C0025)
Article History
Received: 4 April 2021
Accepted: 20 October 2021
First Online: 6 January 2022
Declarations
:
: The trial protocol was approved (SMC 2016-12-127) by the Institutional Review Board at Samsung Medical Center and was conducted by following the Declaration of Helsinki and Guidelines for Good Clinical Practice. All patients provided written informed consent before enrollment.
: Not applicable
: X.L. and R.C. are employees of Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA. The remaining authors declare that they have no competing interests.